Wei Sun
About Wei Sun
Wei Sun is a Senior Director and Medical Safety Assessment Physician at Bristol Myers Squibb with over a decade of experience in medical safety and pharmacovigilance roles.
Company
Wei Sun currently works at Bristol Myers Squibb in Summit East, NJ, USA. In his role as Senior Director, Medical Safety Assessment Physician, he has been involved in medical safety assessment since August 2020. Bristol Myers Squibb is a global biopharmaceutical company, making contributions to the advancement of medical science and patient care.
Title
Wei Sun holds the position of Senior Director, Medical Safety Assessment Physician at Bristol Myers Squibb. His role involves overseeing medical safety assessments, which are crucial for ensuring drug safety and efficacy. His decade-long experience in medical safety and pharmacovigilance underscores his expertise in this field.
Education and Expertise
Wei Sun has an educational background that includes a Doctor of Philosophy (PhD) from Rutgers University, and a Doctor of Medicine (MD) from Tianjin Medical University. His dual qualifications in both research and clinical medicine provide him with a robust foundation for his roles in medical safety and pharmacovigilance.
Professional Background
Wei Sun's professional journey includes roles at several notable organizations. Prior to his current role at Bristol Myers Squibb, he worked at Novartis in various capacities, serving as a Senior Safety Physician from 2016 to 2020, and as a Senior Manager from 2012 to 2015, both in East Hanover, NJ. He also held the position of Senior Medical Director at Pacira Pharmaceuticals, Inc. in Parsippany, NJ from 2015 to 2016. Earlier in his career, he worked as a Sub-Investigator at Robert Wood Johnson University Hospital in New Brunswick, NJ from 2008 to 2012.
Experience in Medical Safety and Pharmacovigilance
Wei Sun has over a decade of experience in the fields of medical safety and pharmacovigilance. His roles have encompassed both managerial and directorial responsibilities, providing him with comprehensive expertise in ensuring the safety and efficacy of pharmaceuticals. His work spans across clinical and pharmaceutical industry settings, reflecting a diverse background in medical safety assessments.